TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. J Clin Oncol. 2020 12 20; 38(36):4274-4282.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Breast Neoplasms
Female
Homologous Recombination
Humans
Middle Aged
Mutation
Neoplasm Metastasis
Phthalazines
Piperazines
Poly(ADP-ribose) Polymerase Inhibitors

authors with profiles

Rita Nanda